
Champions Oncology Inc
NASDAQ:CSBR

Net Margin
Champions Oncology Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
Champions Oncology Inc
NASDAQ:CSBR
|
85.5m USD |
11%
|
|
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
10%
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
180.6B USD |
15%
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
147B USD |
14%
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW |
26%
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.6B CHF |
10%
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
34.7B USD |
9%
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
34.1B USD |
18%
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
242.8B CNY |
27%
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
26.3B USD |
22%
|
|
IN |
![]() |
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1.8T INR |
24%
|
Champions Oncology Inc
Glance View
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Champions Oncology Inc's most recent financial statements, the company has Net Margin of 11%.